EORTC Receptor and Biomarker Study Group report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts

Autor: J. R. Westphal, C.G.J. Sweep, Paul N. Span, Nicolai Grebenchtchikov, J. (Anneke) Geurts-Moespot, A. M. J. Lucassen
Rok vydání: 2000
Předmět:
Vascular Endothelial Growth Factor A
030213 general clinical medicine
Cancer Research
Pathology
Angiogenesis
medicine.medical_treatment
Clinical Biochemistry
The effect of recombinant VGEF (Vascular Endothelial Growth Factor) on experimental angiogenesis after peripheral vascular occlusion in animals
Endothelial Growth Factors
chemistry.chemical_compound
Cytosol
0302 clinical medicine
Antibody Specificity
Protein Isoforms
Receptor
Lymphokines
biology
Vascular Endothelial Growth Factors
Goats
Neoplasm Proteins
Vascular endothelial growth factor
Vascular endothelial growth factor A
Ducks
Oncology
030220 oncology & carcinogenesis
Biomarker (medicine)
Female
Rabbits
Het effect van recombinant VGEF (Vascular Endothelial Growth Factor) op experimentele angiogenese na perifere vaatafsluiting bij het konijn en de rat
Antibody
Artifacts
Dimerization
medicine.medical_specialty
Recombinant Fusion Proteins
Dose-Response Relationship
Immunologic

Antibodies
Heterophile

Breast Neoplasms
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity
Pathology and Forensic Medicine
03 medical and health sciences
Species Specificity
Development of assays for prognostic factors in oncological endocrinology
Biomarkers
Tumor

medicine
Animals
Humans
Immune Sera
Growth factor
Reproducibility of Results
Molecular biology
chemistry
Polyclonal antibodies
Ontwikkeling van meetmethodes voor prognostische factoren in de oncologische endocrinologie
biology.protein
Chickens
Zdroj: International Journal of Biological Markers, 15, 2, pp. 184-191
ResearcherID
International Journal of Biological Markers, 15, 184-191
ISSN: 0393-6155
Popis: A four-antibody sandwich enzyme-linked immunosorbent assay (ELISA) for vascular endothelial growth factor (VEGF) for application in blood (serum and plasma) and tumor tissue extracts was set up within the framework of the EORTC Receptor and Biomarker Study Group (RBSG). Polyclonal antibodies against VEGF165 were raised in chickens and rabbits, and used in a previously described assay format. The assay was validated and characterized for use in serum, plasma and tumor tissue extracts. The resulting VEGF ELISA was found to be specific for VEGF165 and VEGF121, the main isoforms of VEGF. The assay showed good precision and parallelism in serial dilutions of samples. The assay was not susceptible to interference by heterophilic antibodies because avian antibodies (duck anti-chicken and chicken anti-VEGF) were used in the pre-analyte stage and mammalian antibodies (rabbit anti-VEGF and goat anti-rabbit) in the post-analyte stage. In conclusion, a sensitive, robust and specific VEGF ELISA has been developed. Research into the prognostic value of VEGF employing this assay is currently underway.
Databáze: OpenAIRE